Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.

Johnson, Fred L

Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589. [electronic resource] - Platelets Aug 2007 - 346-56 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0953-7104

10.1080/09537100701268741 doi


Adenosine Diphosphate--antagonists & inhibitors
Adenosine Monophosphate--administration & dosage
Adolescent
Adult
Bleeding Time
Blood Platelets--metabolism
Cardiovascular Diseases
Cohort Studies
Double-Blind Method
Female
Hemostasis--drug effects
Humans
Infusions, Intravenous
Male
Middle Aged
Partial Thromboplastin Time
Platelet Aggregation Inhibitors--administration & dosage
Prothrombin Time
Purinergic P2 Receptor Antagonists
Receptors, Purinergic P2--metabolism
Receptors, Purinergic P2Y12